Believe in Progress
In this episode of the Believe in Progress podcast, we talk with stage 4 kidney cancer survivor Katie Coleman and physician-scientist Dr. Pavlos Msaouel, who specializes in rare kidney cancers.
Listen and Subscribe
In this episode of the Believe in Progress podcast, we talk with stage 4 kidney cancer survivor Katie Coleman and physician-scientist Dr. Pavlos Msaouel, who specializes in rare kidney cancers.
Listen and Subscribe
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreFour in 10 cancers diagnosed in the United States each year are related to potentially preventable causes. Learn about cancer risk reduction and prevention.
Read the ReportMore than 66,000 people in the United States are expected to be diagnosed with pancreatic cancer this year, according to federal estimates. Learn about this type of cancer and treatment options.
Learn MoreInvesting in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Read MoreMaking Treatment Decisions: Abigail Johnston shares how she has approached decisions about her cancer care since she was diagnosed with metastatic breast cancer in 2017.
Read Practical KnowledgeWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSubmit an abstract for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: November 26
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
